Day: August 14, 2024

~ Q2 2024 Highlighted by Launch of Innovative Scalable Products, SOUNDZ and Unlockables, New Dedicated Worlds and a Strategic Partnership with Meta-Stadiums~ ~ Net Loss Improvement in Q2 2024 Attributable to Reduced Spend Paves the Way for First Profitable Quarter in Q4 ~ SANTA MONICA, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLE), a leader in redefining the gaming industry as a media channel, has released its second quarter 2024 financial results in the form of a shareholder letter which can be accessed under the Quarterly Results section of the Company’s investor relations website. A webinar hosted by Ann Hand, CEO of Super League, and Clayton Haynes, CFO of Super League, will be streamed here beginning today, Wednesday, August 14, 2024 at 5:00 PM Eastern Time to further discuss the results. Management Commentary...

GEORGE TOWN, Cayman Islands, Aug. 14, 2024 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, reported results for the second quarter ended June 30, 2024. All comparisons are to the same prior year period unless otherwise noted. Consolidated Water will hold a conference call at 11:00 a.m. Eastern time tomorrow to discuss the results (see dial-in information below). Second Quarter 2024 Financial Key PointsTotal revenue declined 27% to $32.5 million. Retail revenue increased 8% to $8.2 million on higher sales volumes. Bulk revenue was relatively consistent at $8.4 million. Manufacturing revenue was relatively consistent at $3.9 million. Services revenue declined by 51% (or approximately $12.2 million) to $11.9...

SALT LAKE CITY, Aug. 14, 2024 (GLOBE NEWSWIRE) — omniQ Corporation (OTCQB: OMQS) (“omniQ” or the “Company”), a leading provider of Artificial Intelligence (AI)-based solutions, today reported revenues of approximately $19.1 million in the second quarter, marking an improvement from the previous quarter. FINANCIAL HIGHLIGHTS: Key Improvements Compared to 2023Gross margin for the three months ended June 30, 2024, substantially increased to 26% compared to 19% in Q2 2023 Gross margin for the six months ended June 30, 2024, increased to 27% compared to 20% in the same period of 2023. Gross profit for the three months ended June 30, 2024, increased by 26% or $1M compared to the second quarter of 2023. Gross Profit for the six months ended June 30, 2024, increased by 4% or $332 thousand compared to the same period...

Midland, Texas, Aug. 14, 2024 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (“NGS” or the “Company”) (NYSE:NGS), a leading provider of natural gas compression equipment, technology, and services to the energy industry, today announced financial results for the three months ended June 30, 2024. The Company also updated its prior guidance for the full year, increasing its outlook for both Adjusted EBITDA and growth capital expenditures. Second Quarter 2024 HighlightsRental revenue of $34.9 million, an increase of 45% when compared to the second quarter of 2023 and 4% sequentially. Net income of $4.3 million, or $0.34 per basic share, as compared to $0.5 million, or $0.04 per basic share in the comparable year-ago period. Adjusted EBITDA of $16.5 million, compared to $9.9 million in the second quarter of 2023 and essentially...

GONZALES, La., Aug. 14, 2024 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) today reported results for the first quarter of fiscal year 2025, which ended June 30, 2024. First Quarter SummaryNet sales of $16.2 million, compared with $17.1 million in the prior-year quarterGross profit was 24.5% of net sales in the current quarter, 27.7% in the prior-year quarterNet loss of $322,000, or $0.03 per shareNet loss includes expenses of approximately $244,000 ($193,000 after tax, or $0.02 per share) associated with the closure of the Company’s subsidiary in the United Kingdom, and approximately $116,000 ($90,000 after tax, or $0.01 per share) of costs associated with the acquisition of Baby Boom Consumer Products (“Baby Boom”)Subsequent to the End of First QuarterAcquired Baby BoomDeclared quarterly...

WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today reported financial results for the second quarter ended June 30, 2024. “We continue to work closely with the Nufarm team to finalize the asset purchase agreement announced in July,” said Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10. “We believe that the transition of our Omega-3 Camelina program to Nufarm is in the best interest of our shareholders, business partners, and employees. Receipt of the initial $3 million payment and progress toward earning an additional $2 million milestone payment is enabling us to manage key biological assets and regulatory requirements, while providing us with the cash runway to secure...

Quarter Highlighted by XFC 50 and XFC Grand Prix Events, Naming of Sports and Entertainment Industry Executive as President DETROIT, Aug. 14, 2024 (GLOBE NEWSWIRE) — Xtreme One Entertainment, Inc. (OTCPink:XONI) (the “Company” or “Xtreme One”) today announced its financial results for the second quarter ending June 30, 2024, details of which have been filed within the Company’s quarterly disclosure statement accessible at https://www.otcmarkets.com/stock/XONI/disclosure. “I’m incredibly proud of the efforts our team demonstrated, as their dedication culminated in the successful production of two live XFC Main events during the quarter, XFC 50 and XFC: Grand Prix II,” commented Chris Defendis, Xtreme One President. “As we continue to evolve in the space, it is clear that our strategy is working; XFC Grand Prix II saw a 52% increase...

MIRAMAR, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its second quarter ended June 30, 2024.  Dr. Hing C. Wong, Founder and CEO of HCW Biologics, stated, “We reached a critical milestone recently that has profound implications for the future of our Company — we successfully reached a settlement agreement for an arbitration that created an overhang that hampered our progress for nearly two years. We wasted no time in launching our multi-faceted financing plan, including a significant equity offering...